LS

Lalit Singh

Active Director Director DIN 09483465
DIN 09483465 First appointment Jan 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Lalit Singh

Data last updated:

Lalit Singh is a Director at Medella Softgel Private Limited (since 2022). The company operates in Pharma. Medella Softgel Private Limited reported revenue of ₹8.9 Lakh (FY 2025).

DIN 09483465
Primary Designation Director
Industry Pharma
First Appointment 28 Jan 2022
Oldest Company Age 4 yrs
Largest company Medella Softgel Private Limited · ₹8.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medella Softgel Private Limited U24303JK2022PTC013114
Director28 Jan 20222022₹8.9 Lakh (FY 2025)Active

Board colleagues of Lalit Singh

NameDINCompanyDesignation
Radhika Singh09483464Medella Softgel Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medella Softgel Private Limited
Premium access

Shareholding and investment profile for Lalit Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalit Singh

Lalit Singh currently holds 1 directorship: Medella Softgel Private Limited (Director, since 28 Jan 2022, revenue ₹8.9 Lakh (FY 2025)).

Lalit Singh was first appointed on 28 Jan 2022 as Director at Medella Softgel Private Limited.

The current boards of Lalit Singh's companies include Radhika Singh (Medella Softgel Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available